| FAST-M: Prolonged Overnight Fasting and Mediterranean Dietary Intervention for Patients With Multiple Myeloma or Its Precursor Disease (NCT07446777) | University of Miami | 2026-04-07 |
| Clonal Hematopoiesis of Immunological Significance (NCT05969821) | Assistance Publique - Hôpitaux de Paris | 2026-04-01 |
| Exploring the Effects of Korean-Style Mediterranean Diet (KORMED) and Physical Activity Measurement in Patients With MGUS/SMM: A Pilot Study (NCT07305662) | Seoul National University Bundang Hospital | 2026-01-30 |
| Determine the Frequency of Variants in the GBA/PSAP Genes in Patients With MM or MGUS (NCT06559033) | University Hospital, Rouen | 2025-10-07 |
| Daratumumab for Polyneuropathy Associated With MGUS (NCT06046287) | Georgetown University | 2025-09-26 |
| Screening for Monoclonal Gammopathy in Individuals Undergoing Physical Examinations Using iMS-LC Assay Technology. (NCT06489613) | Jian Li | 2024-07-01 |
| MGUS/MM Awareness and Genetics Insights Campaign (MAGIC) Screening Study (NCT06472830) | Mayo Clinic | 2024-05-22 |
| Whole Body MRI in Oncology (NCT06895291) | Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS | 2023-10-26 |
| A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS) (NCT06055894) | Memorial Sloan Kettering Cancer Center | 2023-09-20 |
| The China M-protein Screening Project in First-degree Relatives of Myeloma Patient - The CHAPERONE Study (NCT05965115) | Shanghai Zhongshan Hospital | 2023-07-01 |
| Early Detection of Multiple Myeloma to Fight Cancer Disparities: A Screening and Patient Navigation Program (NCT05831358) | Case Comprehensive Cancer Center | 2023-06-16 |
| Promoting Diagnosis and Management of AL in Italy (ProDigALIty) (NCT06383143) | Fondazione IRCCS Policlinico San Matteo di Pavia | 2023-05-01 |
| A Study Comparing a Plant-Based Diet With Supplements and Placebo in People With Monoclonal Gammopathy of Undetermined Significance (MGUS) or Smoldering Multiple Myeloma (SMM) (NCT05640843) | Memorial Sloan Kettering Cancer Center | 2022-11-29 |
| Two Biologically and Clinically Distinct Entities: Progressive Versus Stable Multiple Myeloma (MM) Precursor Conditions (NCT05361694) | University of Miami | 2022-04-12 |
| Curcumin and Piperine in Patients on Surveillance for Monoclonal Gammopathy, Smoldering Myeloma or Prostate Cancer (NCT04731844) | University of Rochester | 2021-12-14 |
| Isatuximab in Type I Cryoglobulinemia (NCT05114109) | Assistance Publique - Hôpitaux de Paris | 2021-11-01 |
| Establishment of Genomic, Transcriptomic and Functional Characteristics of Tumor Cells in Hyperinflammatory Hemopathies (NCT04702932) | Assistance Publique - Hôpitaux de Paris | 2021-09-01 |
| A Study of a Plant-Based Diet in People With Monoclonal Gammopathy of Undetermined Significance (MGUS) or Smoldering Multiple Myeloma (SMM) (NCT04920084) | Memorial Sloan Kettering Cancer Center | 2021-06-03 |
| Investigation of Metformin for the Prevention of Progression of Precursor Multiple Myeloma (NCT04850846) | Dana-Farber Cancer Institute | 2021-04-27 |
| MGUS, SMM, and MM Patient Experience With Coronavirus 19 (COVID-19) Survey (NCT04727294) | HealthTree Foundation | 2021-01-22 |
| Ibrutinib for the Treatment of COVID-19 in Patients Requiring Hospitalization (NCT04439006) | Jennifer Woyach | 2020-10-23 |
| Screening to Improve Survival in AL Amyloidosis (NCT04615572) | Tufts Medical Center | 2020-08-28 |
| Sleep Apnea in Patients With MGUS and MM (NCT04114084) | Michael Tomasson | 2019-05-23 |
| Observation of the Incidence and Natural History of MGUS in Patients Undergoing Weight Reduction Surgery (NCT03855878) | Indiana University | 2018-12-10 |
| Dysregulation of Glutamine Activity in the Pathogenesis of Multiple Myeloma (NCT03119883) | Mayo Clinic | 2017-06-02 |
| Iceland Screens, Treats or Prevents Multiple Myeloma (NCT03327597) | University of Iceland | 2016-09-01 |
| Quality of Life in Patients With Asymptomatic Monoclonal Gammopathies (NCT05136807) | M.D. Anderson Cancer Center | 2016-06-07 |
| Observational Prospective Research Study In Monoclonal Gammopathies leadINg to Myeloma (NCT02726750) | M.D. Anderson Cancer Center | 2015-12-14 |
| B-Cell Hematologic Malignancy Vaccination Registry (NCT02298816) | Wake Forest University Health Sciences | 2014-08-01 |
| Genomic and Psychosocial Effects of the 3RP on Patients With MGUS and Smoldering Multiple Myeloma (NCT01955395) | Dana-Farber Cancer Institute | 2013-10-01 |
| Vaccine Therapy in Preventing Cytomegalovirus Infection in Patients With Hematological Malignancies Undergoing Donor Stem Cell Transplant (NCT01588015) | City of Hope Medical Center | 2012-10-29 |
| Imaging Studies and the Development of Multiple Myeloma (NCT01571726) | National Cancer Institute (NCI) | 2012-03-27 |
| Ohio State University Multiple Myeloma and Amyloidosis Data Registry and Sample Resource (NCT01408225) | Ohio State University Comprehensive Cancer Center | 2011-03-17 |
| Imaging in MGUS, SMM and MM (NCT01237054) | National Cancer Institute (NCI) | 2010-10-17 |
| A Study Evaluating the Effects of Siltuximab on the Heart in Patients With Monoclonal Gammopathy of Undetermined Significance, Smoldering Multiple Myeloma, or Indolent Multiple Myeloma (NCT01219010) | Janssen Research & Development, LLC | 2010-10-01 |
| Natural History Study of Monoclonal Gammopathy of Undetermined Significance (MGUS) and Smoldering Myeloma (SMM) (NCT01109407) | National Cancer Institute (NCI) | 2010-04-22 |
| Study of DNA Copy Numbers Variations and Gene Expression Profile of Bone Marrow Plasma Cells From MGUS and SMM. (NCT01079429) | Rennes University Hospital | 2009-01-12 |
| Prevention of Disease Progression in Early Stage Indolent B Cell Malignancies. (SMM) (NCT00899353) | Marshall University | 2008-08-01 |
| Celecoxib in Preventing Multiple Myeloma in Patients With Monoclonal Gammopathy or Smoldering Myeloma (NCT00099047) | National Cancer Institute (NCI) | 2004-11-01 |
| S0309, Repository: Blood/Bone Marrow From Pts. With Myeloma, WM, Amyloidosis, or MGUS. (NCT00919139) | SWOG Cancer Research Network | 2003-11-01 |
| Imatinib Mesylate in Treating Patients With Advanced Cancer and Liver Dysfunction (NCT00025415) | National Cancer Institute (NCI) | 2001-08-01 |